REDCARE PHARMACY NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.00 EUR | +2.94% |
|
+5.62% | -4.33% |
| Jan. 15 | REDCARE PHARMACY : Berenberg reiterates its Buy rating | ZD |
| Jan. 14 | Redcare Pharmacy: Europe's leading online pharmacy secures its position |  |
Company Valuation: Redcare Pharmacy NV
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 585.7 | 2,658 | 2,050 | 798.2 | 2,395 | 2,563 | 2,563 | - |
| Change | - | 353.83% | -22.87% | -61.07% | 200.06% | 7.02% | 0% | - |
| Enterprise Value (EV) 1 | 621.6 | 2,568 | 2,039 | 986.6 | 2,556 | 2,748 | 2,764 | 2,738 |
| Change | - | 313.09% | -20.59% | -51.62% | 159.04% | 7.54% | 0.59% | -0.94% |
| P/E ratio | -15.6x | -127x | -27.3x | -10.2x | -180x | -63.5x | -273x | 44.3x |
| PBR | 2.44x | 6.91x | 4.94x | 2.26x | 5.09x | 4.89x | 4.92x | 4.49x |
| PEG | - | 2.2x | -0x | -2.49x | 2.2x | -0x | 3.6x | -0x |
| Capitalization / Revenue | 0.84x | 2.75x | 1.93x | 0.66x | 1.33x | 1.08x | 0.87x | 0.72x |
| EV / Revenue | 0.89x | 2.65x | 1.92x | 0.82x | 1.42x | 1.15x | 0.93x | 0.77x |
| EV / EBITDA | -45.8x | 119x | -408x | -123x | 47.8x | 70.6x | 32.6x | 18.1x |
| EV / EBIT | -22.1x | 462x | -63.1x | -20.7x | -674x | -89.5x | -109x | 172x |
| EV / FCF | -13.8x | -72.3x | -64.7x | -11.9x | 110x | -90.9x | -410x | 51.5x |
| FCF Yield | -7.26% | -1.38% | -1.55% | -8.38% | 0.91% | -1.1% | -0.24% | 1.94% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.78 | -1.17 | -4.15 | -4.32 | -0.73 | -1.984 | -0.4609 | 2.842 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 701 | 968.1 | 1,060 | 1,204 | 1,799 | 2,380 | 2,962 | 3,568 |
| EBITDA 1 | -13.57 | 21.62 | -5 | -8.044 | 53.5 | 38.93 | 84.81 | 151.5 |
| EBIT 1 | -28.18 | 5.556 | -32.3 | -47.55 | -3.793 | -30.7 | -25.3 | 15.9 |
| Net income 1 | -36.27 | -16.77 | -74.2 | -77.65 | -12.04 | -39.38 | -10.4 | 50.86 |
| Net Debt 1 | 35.97 | -90.02 | -10.98 | 188.4 | 160.7 | 185.1 | 201.3 | 175.3 |
| Reference price 2 | 43.50 | 148.20 | 113.30 | 44.11 | 131.60 | 126.00 | 126.00 | 126.00 |
| Nbr of stocks (in thousands) | 13,464 | 17,935 | 18,095 | 18,095 | 18,199 | 20,342 | 20,342 | - |
| Announcement Date | 3/17/20 | 3/3/21 | 3/2/22 | 3/7/23 | 3/5/24 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E ratio | EV / Sales | EV / EBITDA | Yield | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -63.51x | 1.15x | 70.59x | -.--% | 2.69B | ||
| 29.01x | 1.27x | 38.93x | -.--% | 12.79B | ||
| -20.49x | 0.12x | 5.35x | +8.42% | 10.26B | ||
| 28.3x | 1.31x | 22x | -.--% | 7.06B | ||
| 17.81x | 0.76x | 8.11x | +1.85% | 5.92B | ||
| 24.79x | 1.59x | 12.15x | +2.55% | 4.44B | ||
| 18.36x | 1.67x | 10.2x | +4.47% | 4.09B | ||
| 17.57x | 0.98x | 7.07x | +2.08% | 3.8B | ||
| 23.17x | 0.4x | 9.16x | +1.64% | 2.96B | ||
| Average | 8.33x | 1.03x | 20.40x | +2.33% | 6B | |
| Weighted average by Cap. | 11.40x | 0.98x | 20.29x | +2.59% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- RDC Stock
- Valuation Redcare Pharmacy NV